Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3769898018 | Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3769899014 | Nonacog alfa 250 international unit lyophilized powder for solution for injection vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3786517014 | Nonacog alfa 250 international unit lyophilised powder for solution for injection vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | Nonacog alfa | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has unit of presentation | Vial | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Plays role | Hemostatic therapeutic role | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has basis of strength substance | Nonacog alfa | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator unit | international unit | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator unit | Vial | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Lyophilized powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Is a | Product containing only nonacog alfa in parenteral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator value | 250 | false | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR